CN103386024B - Traditional Chinese medicine preparation for treating pancreas cancer and preparation method thereof - Google Patents
Traditional Chinese medicine preparation for treating pancreas cancer and preparation method thereof Download PDFInfo
- Publication number
- CN103386024B CN103386024B CN201310270680.4A CN201310270680A CN103386024B CN 103386024 B CN103386024 B CN 103386024B CN 201310270680 A CN201310270680 A CN 201310270680A CN 103386024 B CN103386024 B CN 103386024B
- Authority
- CN
- China
- Prior art keywords
- weight portions
- radix
- chinese medicine
- medicine preparation
- rhizoma
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a traditional Chinese medicine preparation for treating pancreas cancer and a preparation method thereof, wherein the raw materials of the traditional Chinese medicine preparation comprises the following medicinal materials: herbal sarcandrae, aspongopus, Tripterygium wilfordii Hook f, cremastra, cuttlefish bone, forged concha arcae, flat shaft wood, rhizoma atractylodis, bighead atractylodes rhizome, crab shell, ovalleaf dutchmanspipe root, Chinese yam, magnolia cortex, flat bamboo root, fried white peony root, honey-fried licorice root, herb of false indigo, moonseed, root of caudate milkwort, solanum dulcamara, wrinkled giant hyssop, pinellia and Radix Codonopsis. The beneficial effects of the traditional Chinese medicine preparation are as follows: the traditional Chinese medicine preparation can be used alone or together with chemicotherapy, and is clinically applied for treating pancreas cancer treatment, reducing the phyma in a short period, effectively controlling the transfer and diffusion of the cancer cell, inhibiting the growth of the cancer cell without any side-effect at the same time, enhancing body immunity, alleviating pain, stabilizing condition, prolonging lifetime and increasing clinic healing proportion while curing cancer and preventing cancer, and can prevent the residual cancer cell from starting over, and substantially reduce recurrence and transfer.
Description
Technical field
The present invention relates to technical field of Chinese medicines, relate in particular to a kind of Chinese medicine preparation that is used for the treatment of cancer of pancreas and preparation method thereof.
Background technology
Cancer of pancreas is more rare in malignant tumor of digestive tract, is more common in 40～60 years old, and man is more than female, and cancer of pancreas mostly occurs at Diseases In Pancreatic Head, and only minority occurs in body of pancreas and tail of pancreas portion.Cancer of pancreas is due to the position of cancerous protuberance generation and the morning and evening difference of the course of disease, and clinical symptoms is different.The symptom of stomachache for occurring the earliest, is more common in body of pancreas and tail of pancreas portion, large multidirectional lower back radiation.The state of an illness can have jaundice in evolution, and abdominal mass can appear in late period, heating, and supraclavicular lymph nodes is modal metastasis site.Modern medicine thinks that primary disease may be relevant with chronic pancreatic diseases with carcinogen in environment, coffee, smoking.Cancer of pancreas is a kind of comparatively dangerous malignant tumor, although nearly 1 people suffers from cancer of pancreas in every 20,000 people of China, the fast-growth case fatality rate of this disease is high.NIH's report, 1 year survival rate of cancer of pancreas is 8%, 5 year survival rate 3%.5 years survival rates of China's Statistical data are 5% left and right only.Sickness rate significantly rises year by year in recent years, and U.S.'s cancer of pancreas sickness rate raise 3 times between 10 years, neopathy 43140 examples in 2010, and dead 36800 examples, occupy the tenth of Incidence, and mortality rate is but in the 4th.China's cancer of pancreas morbidity and death toll ascendant trend be highly significant especially, and nearly 20 annual morbidities increase approximately 6 times.According to 38 registry, whole nation tumor registration data in 2007, cancer of pancreas morbidity occupies the 7th of malignant tumor, and case fatality rate occupies the 6th of malignant tumor.
The total pathogenesis of cancer of pancreas is that weakness of the spleen and stomach, depression of liver-QI cause the stagnation of QI, blood stasis, damp and hot for suffering from, and forms for a long time hard piece.Carcinoma of head of pancreas shows as manyly with damp and hot, and body of pancreas, carcinoma of tail of pancreas be the card of the common insufficiency of the spleen stagnation of QI.The treatment in cancer of pancreas late period should or be attacked or mend or reinforcement and elimination in combination according to disease different phase.
Cancer of pancreas be take operative treatment in early days as main, and postoperative suitable chemotherapy, in conjunction with long-term Chinese medicine, likely obtains good efficacy; Many operations palliative treatments in mid-term, as unresectable, feasible cholecystojejunostomy to be to alleviate jaundice, and Chinese medicine simultaneously also can Combined with Radiotherapy, chemotherapy etc.; Chinese medicine and symptomatic treatment take late period as main, or in conjunction with small dose chemotherapy.Cancer of pancreas Chinese traditional treatment in late period adopts the method for heat-clearing and toxic substances removing, dissipating phlegm and resolving masses, regulating qi-flowing for strengthening spleen more.
Cancer of pancreas belongs to the traditional Chinese medical science " fullness in the epigastrium especially referring to the abcess of the abdomen in ancient times ", " mass in the abdomen ", " jaundice ", the category such as " gather ", its cause of disease, pathogenesis is mainly internal injury caused by excess of seven emotions, eating and drinking without temperance and to cause liver spleen impaired, internal organs are become estranged, turbid damp retardance, qi depression to blood stasis, with the passing of time form primary disease, in < <, through > >, also early have recognized that the relation of primary disease and diet delicious food and jaundice, as < < Plain Questions is logical, comment deficiency and excess opinion > > to say: " diseases due to endogenous heat of ZANG FU organs sudden falling down, hemiplegia flaccidity with cold limbs, fullness caused by stagnant QI is sent out contrary, sweet fertile high official, the disease of Sorghum vulgare Pers. also ".The traditional Chinese medical science thinks that primary disease is many by depression of liver-QI, due to functional activity of QI being not smooth, insufficiency of the spleen for a long time, insufficiency of the spleen resulting in production of dampness, and strongly fragrant and heat-transformation, with the passing of time delay, causes qi depression to blood stasis, knot in pyretic toxicity.Therefore the methods such as depressed liver-energy dispersing and function of gallbladder promoting, blood circulation promoting and blood stasis dispelling, clearing away heat-damp and promoting diuresis, removing mass eliminating stagnation that adopt in treatment more.
Cancer of pancreas early symptom is not also true to type, often show as the symptom that is similar to other organs pathological changes, cause some Symptomatic by sing misdiagnosis and mistreatment, great majority are diagnosed as cancer of pancreas, and person has been has metastasis or to the advanced pancreatic cancer of metastasis sign, but doctor trained in Western medicine is to cancer of pancreas treatment of late stage poor effect, can only be operation, radiotherapy, chemotherapy, cut again and cut, until life finishes, patient spends always in misery, only has less than 20% patient to exist radical operation to wish.Most of Pancreas cancer patients there will be the symptoms such as weight loss, stomachache, jaundice, appetite be poor, can there is epigastric discomfort, abdominal distention, weak symptom in half left and right patient, about twenty percent patient has lumbago and backache, diarrhoea, melena, and losing weight is the most common symptom of Pancreas cancer patients.Early stage patient cardinal symptom is that epigastric discomfort, appetite are poor, abdominal distention, weak, once there is weight loss, stomachache, jaundice, pointing out may be middle and advanced stage.The traditional Chinese medical science claims that pancreas is that spleen is long-pending, and pancreas jaundice, stomachache are all caused by insufficiency of the spleen.At present, clinical many single method treatment advanced pancreatic cancer that do not adopt, adopt Chinese medicine integrated approach more, to control to greatest extent the evolution of tumor, alleviate patient's misery, improve quality of life of patients, extend patients ' lives.
Summary of the invention
Technical problem to be solved by this invention is, utilize the traditional theory of Chinese medical science of China, provide that a kind of side effect is little, good effect, cost are low, have no drug resistance, alleviate patient's misery, improve quality of life of patients, extend the Chinese medicine preparation and preparation method thereof of the treatment cancer of pancreas of patients ' lives.
For solving the problems of the technologies described above, the invention provides a kind of Chinese medicine preparation for the treatment of cancer of pancreas, its raw medicinal material comprises: Herba Sarcandrae, Aspongopus, Radix Tripterygii Wilfordii, Pseudobulbus cremastrae seu pleiones, Os Sepiae, Concha Arcae (calcined), Radix Parkinsoniae, Rhizoma Atractylodis, the Rhizoma Atractylodis Macrocephalae, Carapax Eriocheir sinensis, Radix Aristolochiae Tagalae, Rhizoma Dioscoreae, Cortex Magnoliae Officinalis, Rhizoma Iridis Japonicae, Radix Paeoniae Alba (parched), Radix Glycyrrhizae Preparata, Herba indigoferae Pseudotinctoriae, asiatic moonseed, Radix Polygalae Caudatae, Herba Solani Lyrati, Herba Pogostemonis, Rhizoma Pinelliae (processed with Rhizoma Zingiberis Recens) and Radix Codonopsis.
Wherein, in described Chinese medicine preparation, the ratio of weight and number of each raw medicinal material is: Herba Sarcandrae 35～45 weight portions, Aspongopus 15～25 weight portions, Radix Tripterygii Wilfordii 6～15 weight portions, Pseudobulbus cremastrae seu pleiones 15～30 weight portions, Os Sepiae 20～40 weight portions, Concha Arcae (calcined) 15～35 weight portions, Radix Parkinsoniae 10～20 weight portions, Rhizoma Atractylodis 10～25 weight portions, the Rhizoma Atractylodis Macrocephalae 15～30 weight portions, Carapax Eriocheir sinensis 10～20 weight portions, Radix Aristolochiae Tagalae 20～30 weight portions, Rhizoma Dioscoreae 25～40 weight portions, Cortex Magnoliae Officinalis 15～25 weight portions, Rhizoma Iridis Japonicae 10～15 weight portions, Radix Paeoniae Alba (parched) 15～20 weight portions, Radix Glycyrrhizae Preparata 20～35 weight portions, Herba indigoferae Pseudotinctoriae 10～25 weight portions, asiatic moonseed 15～35 weight portions, Radix Polygalae Caudatae 20～35 weight portions, Herba Solani Lyrati 15～30 weight portions, Herba Pogostemonis 15～30 weight portions, Rhizoma Pinelliae (processed with Rhizoma Zingiberis Recens) 15～20 weight portions and Radix Codonopsis 20～30 weight portions.
Wherein, in described Chinese medicine preparation, the ratio of weight and number of each raw medicinal material is: Herba Sarcandrae 35～40 weight portions, Aspongopus 20～25 weight portions, Radix Tripterygii Wilfordii 6～12 weight portions, Pseudobulbus cremastrae seu pleiones 15～20 weight portions, Os Sepiae 20～30 weight portions, Concha Arcae (calcined) 25～30 weight portions, Radix Parkinsoniae 15～20 weight portions, Rhizoma Atractylodis 15～25 weight portions, the Rhizoma Atractylodis Macrocephalae 15～20 weight portions, Carapax Eriocheir sinensis 10～15 weight portions, Radix Aristolochiae Tagalae 20～25 weight portions, Rhizoma Dioscoreae 30～40 weight portions, Cortex Magnoliae Officinalis 20～25 weight portions, Rhizoma Iridis Japonicae 12～15 weight portions, Radix Paeoniae Alba (parched) 18～20 weight portions, Radix Glycyrrhizae Preparata 20～30 weight portions, Herba indigoferae Pseudotinctoriae 10～20 weight portions, asiatic moonseed 20～30 weight portions, Radix Polygalae Caudatae 25～35 weight portions, Herba Solani Lyrati 15～25 weight portions, Herba Pogostemonis 18～25 weight portions, Rhizoma Pinelliae (processed with Rhizoma Zingiberis Recens) 15～17 weight portions and Radix Codonopsis 20～26 weight portions.
Wherein, in described Chinese medicine preparation, the ratio of weight and number of each raw medicinal material is: Herba Sarcandrae 37 weight portions, Aspongopus 23 weight portions, Radix Tripterygii Wilfordii 8 weight portions, Pseudobulbus cremastrae seu pleiones 18 weight portions, Os Sepiae 26 weight portions, Concha Arcae (calcined) 28 weight portions, Radix Parkinsoniae 17 weight portions, Rhizoma Atractylodis 22 weight portions, the Rhizoma Atractylodis Macrocephalae 16 weight portions, Carapax Eriocheir sinensis 14 weight portions, Radix Aristolochiae Tagalae 21 weight portions, Rhizoma Dioscoreae 37 weight portions, Cortex Magnoliae Officinalis 22 weight portions, Rhizoma Iridis Japonicae 14 weight portions, Radix Paeoniae Alba (parched) 18 weight portions, Radix Glycyrrhizae Preparata 25 weight portions, Herba indigoferae Pseudotinctoriae 12 weight portions, asiatic moonseed 29 weight portions, Radix Polygalae Caudatae 33 weight portions, Herba Solani Lyrati 18 weight portions, Herba Pogostemonis 21 weight portions, Rhizoma Pinelliae (processed with Rhizoma Zingiberis Recens) 16 weight portions and Radix Codonopsis 23 weight portions.
When the dosage form of described Chinese medicine preparation is tablet, its preparation method comprises the following steps:
The first step, Herba Sarcandrae, Aspongopus, Radix Tripterygii Wilfordii, Pseudobulbus cremastrae seu pleiones, Os Sepiae, Concha Arcae (calcined), Radix Parkinsoniae, Rhizoma Atractylodis, the Rhizoma Atractylodis Macrocephalae, Carapax Eriocheir sinensis, Radix Aristolochiae Tagalae, Rhizoma Dioscoreae magnolia obovata are mixed, the alcohol reflux that to add with respect to 5 times～8 times, mixture amount determining alcohols be 70%～85% 2 times～4 times, each 3～6 hours, filter; Each time filtrate merges, and reclaims ethanol, is concentrated into the mastic that 70 ℃ of relative densities are 1.34～1.36, standby;
Second step, is mixed in proportion surplus stock medical material, adds with respect to 4～8 times of water gagings of mixture, boils 3～6 hours, filters, and is concentrated into the mastic that 70 ℃ of relative densities are 1.29～1.31;
The 3rd step, the mastic that the first step, second step are obtained mixes, and 60 ℃～70 ℃ reduced vacuum are dry, and powder gets dry extract;
The 4th step, mixes processing by described dried cream powder and starch, obtains mastic mixture; The weight ratio of described dried cream powder and starch is 1: 0.05～0.15; Described mastic mixture is carried out to pelletization treatment, dried, obtain mastic compound particles;
The 5th step, mixes processing, tabletting processing, Cotton seeds successively by described mastic compound particles and Pulvis Talci, magnesium stearate, obtains Chinese medicine preparation tablet finished product; The weight ratio of described mastic compound particles, Pulvis Talci, magnesium stearate is 100: 2～6: 0.1～0.25.
When the dosage form of described Chinese medicine preparation is oral solutions, its preparation method comprises the following steps:
The first step, Herba Sarcandrae, Aspongopus, Radix Tripterygii Wilfordii, Pseudobulbus cremastrae seu pleiones, Os Sepiae, Concha Arcae (calcined), Herba indigoferae Pseudotinctoriae, asiatic moonseed, Radix Polygalae Caudatae and Herba Solani Lyrati are mixed in proportion, the methanol that is 80%～90% with determining alcohol is as solvent, adopt percolation with the speed of 1～3ml per minute percolation slowly, collect percolate, concentrating under reduced pressure is also dry, obtains and gets dry extract, be ground into powder, the quality of the methanol adding is 5～10 times of first step mixture quality;
Second step, is mixed in proportion surplus stock medical material, is ground into powder; Add the distilled water with respect to 4～8 times of powder qualities, decoct 3～6 hours, filter, obtain the first filtrate; Filtering residue is added to the distilled water with respect to 3～5 times of its quality, decoct 2～4 hours, filter, obtain the second filtrate; Merge the first filtrate and the second filtrate, concentrate away the water of 2/3～3/4 volume, adding determining alcohol is 90%～95% ethanol, makes determining alcohol reach 60%～75%, standing 18～36 hours, filter, and concentrating under reduced pressure, dry, obtain and get dry extract, be ground into powder;
The 3rd step, mixes the powder of the first step and second step acquisition, adds the distilled water with respect to 2～6 times of amounts of mixed-powder quality, the sucrose of 0.15～0.35 times, the sodium benzoate of 0.02～0.04 times, stirs, and boils, cooling, filter, subpackage, sterilizing obtains oral liquid.
Beneficial effect of the present invention: Chinese medicine preparation provided by the invention, can be used alone, also can Combined with Radiotherapy chemotherapy use, utilize the traditional theory of Chinese medical science of China, clinical practice is in the treatment of cancer of pancreas, its effect can be dwindled lump in a short time, effectively control cancer cell metastasis diffusion, anticancer growth, do not have side effects again simultaneously, for cancer anticancer in, enhancing human body immunity power, and alleviate patient suffering, stablize the state of an illness, the object that extends life cycle and increase clinical cure patient's ratio, and can prevent that remaining cancerous cell from staging a comeback, greatly reduce relapse and metastasis.
The specific embodiment
The invention provides a kind of Chinese medicine preparation for the treatment of cancer of pancreas, its raw medicinal material comprises: Herba Sarcandrae, Aspongopus, Radix Tripterygii Wilfordii, Pseudobulbus cremastrae seu pleiones, Os Sepiae, Concha Arcae (calcined), Radix Parkinsoniae, Rhizoma Atractylodis, the Rhizoma Atractylodis Macrocephalae, Carapax Eriocheir sinensis, Radix Aristolochiae Tagalae, Rhizoma Dioscoreae, Cortex Magnoliae Officinalis, Rhizoma Iridis Japonicae, Radix Paeoniae Alba (parched), Radix Glycyrrhizae Preparata, Herba indigoferae Pseudotinctoriae, asiatic moonseed, Radix Polygalae Caudatae, Herba Solani Lyrati, Herba Pogostemonis, Rhizoma Pinelliae (processed with Rhizoma Zingiberis Recens) and Radix Codonopsis.
The herbal pharmacology of each raw medicinal material is as follows:
Herba Sarcandrae: be the dry herb of Chloranthaceae plant plait Corallium Japonicum Kishinouye Sarcandra glabra (Thunb.) Nakai.Summer, Qiu Erji gather, and remove impurity, shine in.Another name: the Psychotria rubra (Lour.) Poir. bitter edible plant, Herba Pileae Scriptae, synthetism lotus, Vanda amesiana Reichb. F.Bitter in the mouth, pungent, property is flat.GUIXIN, Liver Channel.Clearing away heat and cooling blood, the speckle removing of invigorating blood circulation, dispelling wind and removing obstruction in the collateral.For heat in blood, send out speckle dermexanthesis, rheumatic arthralgia, traumatic injury.Cure mainly pneumonia, appendicitis, cellulitis, rheumatic arthralgia, injury from falling down, tumor etc.
Aspongopus: become temperature.Return liver,spleen,kidney warp.Regulating QI to relieve pain, warming middle-JIAO is supporing yang.For cold syndrome of the stomach distending pain, stomachache due to hyperactive liver-QI attacking the stomach, impotence due to deficiency of the kidney, soreness of waist and knee joint.
Radix Tripterygii Wilfordii: hardship; Pungent; Large poison.GUIXIN; Liver Channel.Expelling wind and removing dampness; Promoting blood circulation to remove obstruction in the collateral; Reducing swelling and alleviating pain; Parasite killing removing toxic substances.Main classes rheumatic arthritis; Rheumatic arthritis; Glomerulonephritis; Nephrotic syndrome; Lupus erythematosus; Mouth xerophthalmia scheorma syndrome; Behcet disease; Eczema; Psoriasis; Leprosy; Scabies; Stubborn dermatitis
Pseudobulbus cremastrae seu pleiones: sweet, micro-pungent, cold.Enter liver, spleen channel.Detumescence, eliminating stagnation, reduces phlegm, removing toxic substances.Control carbuncle furuncle swollen, scrofula, sore throat swells and ache, Serpentis, worm, mad dog wound.
Os Sepiae: one-tenth, puckery, temperature.Return spleen, kidney channel.Astringing to arrest bleeding, relieving leukorrhea by astringents, antacid, sore.Be used for the acid regurgitation of having a stomachache, hematemesis and epistaxis, metrorrhagia is had blood in stool, emission and spermatorrhea, leucorrhea with red and white discharge; Peptic Ulcers.External treatment bleeding due to trauma, the many pus of skin ulcer.
Concha Arcae: become, flat.Return lung, stomach, Liver Channel.Expectorant blood stasis dispelling, hard masses softening and resolving, relieving gastric hyperacidity to alleviate stomachache.For the long-pending knot of pertinacious phlegm, sticky difficulty is coughed up, goiter, scrofula, lump in the abdomen mass in the abdomen, stomachache pantothenic acid.Concha Arcae (calcined): clean Concha Arcae is put in pot, and upper cover is slightly little pot flatly, and obturaging with yellow mud in place, gap, does not make gas leakage, above the bottom of a pan paste a blank sheet of paper and press with weight, be calcined to pasted blank sheet of paper flavescence, taking-up is dried in the air cool, pulverizes.Also Concha Arcae can be put in crucible or in other vessel, in smokeless stove fire, be calcined to and be popular in, taking-up is dried in the air cool, pulverizes.
Radix Parkinsoniae: taste is micro-sweet; Property is put down.Return kidney; Spleen channel.Tonification.Main health is weak; Impairment caused by overstrain is weak; Deficiency-heat; Spontaneous perspiration; Night sweat.
Rhizoma Atractylodis: pungent, bitter, temperature.Return spleen, stomach, Liver Channel.Drying damp and strengthening spleen, expelling wind and cold, improving eyesight.For distension and fullness in the abdomen, have loose bowels, edema, beriberi flaccidity is preesed, rheumatic arthralgia, anemofrigid cold, nyctalopia.
The Rhizoma Atractylodis Macrocephalae: bitter, sweet, temperature.Return spleen, stomach warp.Invigorating the spleen and benefiting QI, dampness diuretic, hidroschesis, antiabortive.For insufficiency of the spleen lack of appetite, abdominal distention is had loose bowels, phlegm retention vertigo and palpitation, edema, spontaneous perspiration, frequent fetal movement.Rhizoma Atractylodis Macrocephalae spleen invigorating, stomach function regulating, antiabortive.For insufficiency of the spleen lack of appetite, the loose stool of having loose bowels, frequent fetal movement.
Carapax Eriocheir sinensis: taste becomes; Cold in nature.Return liver; Spleen channel.Scattered silt hemostasis; Removing toxic substances and promoting subsidence of swelling.Main jaundice due to accumulation of stagnant blood; Hemostagnant metrorrhagia; Carbuncle pyogenic infections from tumour or sore; Acute gangrenous stomatitis; Insect bite.
Radix Aristolochiae Tagalae: hardship; Pungent; Temperature; Mild toxicity.Return lung; Stomach; Kidney channel.Dispel the wind; Analgesia; Detumescence; Removing toxic substances.Main rheumatic ostalgia; Gastric abscess; Stomachache; Pharyngolaryngitis; Traumatic injury; Infantile convulsion; Venom
Rhizoma Dioscoreae: sweet, flat.Return spleen, lung, kidney channel.Spleen reinforcing nourishing the stomach, the lung benefiting that promotes the production of body fluid, the kidney invigorating arresting seminal emission.For insufficiency of the spleen lack of appetite, incessant chronic diarrhea, the deficiency of the lung is breathed with cough, emission due to deficiency of the kidney, and leukorrhagia, frequent micturition, deficiency-heat is quenched one's thirst.Rhizoma Dioscoreae (parched with bran) spleen reinforcing stomach invigorating.For insufficiency of the spleen lack of appetite, the loose stool of having loose bowels, leukorrhagia.
Cortex Magnoliae Officinalis: bitter, pungent, temperature.Return spleen, stomach, lung, large intestine channel.Dampness expectorant, the therapeutic method to keep the adverse QI flowing downwards is except full.For humidity hysteresis damaging the spleen and stomach, gastral cavity painful abdominal mass is vomited and diarrhoea, stagnation of QI due to dyspepsia, and abdominal distention constipation, phlegm retention is breathed with cough.
Rhizoma Iridis Japonicae: hardship; Pungent; Cold; Slightly poisonous.Help digestion; Parasite killing; Relieving constipation; Diuretic; Invigorate blood circulation; Pain relieving; Removing toxic substances.Main dyspeptic abdominal distention; Abdominal pain due to worm stagnation; Pyroretentional abdominalgia; Constipation with heat retention; Edema; WEIJIA; Cruel for a long time; Toothache; Laryngopharynx swelling and pain; Skin ulcer is swollen; Scrofula; Traumatic injury; Uterine prolapse; Serpentis lyssodexis wound.
The Radix Paeoniae Alba: bitter, sour, be slightly cold.Return liver, spleen channel.Suppressing the hyperactive liver pain relieving, nourishing blood for regulating menstruation, astringing YIN to stop sweating.Be used for having a headache dizzy, hypochondriac pain, stomachache, limb pain twin, blood deficiency and yellow complexion, menoxenia, spontaneous perspiration, night sweat.Radix Paeoniae Alba (parched): get clean Radix Paeoniae Alba sheet, fry to micro-yellow in pot.
Radix Glycyrrhizae: sweet, flat.GUIXIN, lung, spleen, stomach warp.Invigorating the spleen and replenishing QI, heat-clearing and toxic substances removing, expelling phlegm for arresting cough, relieving spasm to stop pain, coordinating the actions of various ingredients in a prescription.For weakness of the spleen and stomach, fatigue and weakness, shortness of breath and palpitation, cough with copious phlegm, gastral cavity abdomen, the anxious pain of extremity contraction, carbuncle sore tumefacting virus, cushion toxicity, strong.Radix Glycyrrhizae Preparata: Radix Glycyrrhizae tabellae is added to cooked Mel and a little boiled water, slightly vexed after mixing thoroughly, put and in pot, fry to buff with when tack-free, take out dry in the air cool (25～30 jin of the cooked Mel of every 100 jin of use).
Herba indigoferae Pseudotinctoriae: bitter in the mouth; Puckery; Property is put down.Return spleen, stomach warp.Clearing away heat and expelling pathogen in the exterior; Dissipating blood stasis removing food stagnancy.Main anemopyretic cold; Cough due to lung-heat; Burn and scald; Furuncle; Venom; Scrofula; Traumatic injury; Dyspeptic abdominal distention.
Asiatic moonseed: hardship; Cold.Return liver; Lung; Intestinal warp.Heat-clearing and toxic substances removing; Reducing swelling and alleviating pain.Main lumbago; Scrofula; Laryngopharynx swelling and pain; Diarrhoea dysentery; Swelling and pain of hemorrhoid.
Radix Polygalae Caudatae: sweet; Micro-hardship; Cool in nature.GUIXIN; Liver; Kidney channel.Clearing away heat-damp and promoting diuresis; Preventing phlegm from forming and stopping coughing.Main laryngopharynx swelling and pain; Jaundice due to damp-heat; Bronchitis.
Herba Solani Lyrati: hardship, is slightly cold.Slightly poisonous.Enter liver, stomach warp.Heat-clearing and toxic substances removing, inducing diuresis and reducing edema, anticancer.Herb: for cold, fever, acute mastitis, malignant boil, jaundice due to damp-heat, ascites, leucorrhea, oedema due to nephritis; Carbuncle furuncle and phyma poison is controlled in external.Root: rheumatic arthralgia.(selecting from < < whole nation Chinese herbal medicine compilation > >).In the present invention with all herbal medicine.
Herba Pogostemonis: acrid in the mouth; Slightly warm in nature.Return lung; Spleen; Stomach warp.Dispelling summer-heat from superficies of the body; Removing dampness to restore normal function of the stomach.Main summertime flu; Cold and heat headache; Breast gastral cavity painful abdominal mass is vexed; Vomiting is had loose bowels; Vomiting during pregnancy; Nasal sinusitis; Hands; Tinea pedis.
The Rhizoma Pinelliae: pungent, temperature; Poisonous.Return spleen, stomach, lung meridian.Drying dampness to eliminate phlegm, stopping nausea and vomiting by lowering the adverse flow of QI, dissolving lump and resolving mass.For abundant expectoration cough with asthma, phlegm retention vertigo and palpitation, dizziness due to wind-phlegm, syncope due to accumulation of phlegm headache, vomiting regurgitation, breast gastral cavity painful abdominal mass is vexed, globus hystericus; Raw with external treatment carbuncle sucutaneous nodule.Rhizoma Pinelliae (processed with Rhizoma Zingiberis Recens) is used for stopping nausea and vomiting by lowering the adverse flow of QI.Rhizoma Pinelliae (processed with Rhizoma Zingiberis Recens): get the clean Rhizoma Pinelliae, size separately, is soaked in water to interior during without the dry heart; Separately get Rhizoma Zingiberis Recens section and decoct soup, add Alumen and the Rhizoma Pinelliae well-done altogether, take out, dry in the air to half-dried, shave, dry.Every 100kg Rhizoma Pinelliae, with Rhizoma Zingiberis Recens 25kg, Alumen 12.5kg.This product is that lamellar, irregular particle shape or class are spherical.Surface is brown to sepia.Matter is firmly crisp, and section is fallow, normal tool cutin sample gloss.Feeble QI is fragrant, and lightly seasoned, micro-have a numb feeling in the tongue, and that chews slightly sticks to one's teeth.
Radix Codonopsis: sweet in the mouth, property is flat.Return spleen, lung meridian.Invigorating the spleen and replenishing QI, spleen invigorating lung benefiting.For deficiency of the spleen and lung, the cardiopalmus of breathing hard, anorexia and loose stool, dyspnea due to deficiency cough, interior-heat is quenched one's thirst.The just > > of < < book on Chinese herbal medicine carries: Radix Codonopsis power energy spleen reinforcing nourishing the stomach, and the lung moistening and production of body fluid promoting, gas in tendon fortune, this is very mutually not far away with Radix Ginseng.Its outstanding valuable person, spleen invigorating fortune and not dry, grows stomach-Yin and wet, and lung moistening and do not violate is cold and coolly nourished blood and is not partially grown greasyly, inspires clear sun, gas in vibration, and without just dry fraud.Radix Codonopsis has QI invigorating strengthening the spleen, the effect of nourishing blood to promote the production of body fluid, be mainly used in deficiency of both the splenic and pulmonary QI or QI and blood deficiency fatigue and weakness, breathe hard, symptom such as cough spontaneous perspiration etc., Radix Codonopsis is longer than spleen reinforcing nourishing the stomach, adjusts regulating the function of middle-JIAO, has the effect of nourishing blood concurrently, its property is flat, spleen invigorating fortune and not dry; Flavour is cloudy and not wet, can improve the immune state of body, improves resistance against diseases, facilitating digestion absorbs, and improves metabolism, promotes the absorption of intestinal to nutrient substance, Radix Codonopsis has certain antitumor assosting effect, can suppress the growth of gross tumor volume and weight, and reduces and shift.
Wherein, in described Chinese medicine preparation, the ratio of weight and number of each raw medicinal material is: Herba Sarcandrae 35～45 weight portions, Aspongopus 15～25 weight portions, Radix Tripterygii Wilfordii 6～15 weight portions, Pseudobulbus cremastrae seu pleiones 15～30 weight portions, Os Sepiae 20～40 weight portions, Concha Arcae (calcined) 15～35 weight portions, Radix Parkinsoniae 10～20 weight portions, Rhizoma Atractylodis 10～25 weight portions, the Rhizoma Atractylodis Macrocephalae 15～30 weight portions, Carapax Eriocheir sinensis 10～20 weight portions, Radix Aristolochiae Tagalae 20～30 weight portions, Rhizoma Dioscoreae 25～40 weight portions, Cortex Magnoliae Officinalis 15～25 weight portions, Rhizoma Iridis Japonicae 10～15 weight portions, Radix Paeoniae Alba (parched) 15～20 weight portions, Radix Glycyrrhizae Preparata 20～35 weight portions, Herba indigoferae Pseudotinctoriae 10～25 weight portions, asiatic moonseed 15～35 weight portions, Radix Polygalae Caudatae 20～35 weight portions, Herba Solani Lyrati 15～30 weight portions, Herba Pogostemonis 15～30 weight portions, Rhizoma Pinelliae (processed with Rhizoma Zingiberis Recens) 15～20 weight portions and Radix Codonopsis 20～30 weight portions.
Wherein, in described Chinese medicine preparation, the ratio of weight and number of each raw medicinal material is: Herba Sarcandrae 35～40 weight portions, Aspongopus 20～25 weight portions, Radix Tripterygii Wilfordii 6～12 weight portions, Pseudobulbus cremastrae seu pleiones 15～20 weight portions, Os Sepiae 20～30 weight portions, Concha Arcae (calcined) 25～30 weight portions, Radix Parkinsoniae 15～20 weight portions, Rhizoma Atractylodis 15～25 weight portions, the Rhizoma Atractylodis Macrocephalae 15～20 weight portions, Carapax Eriocheir sinensis 10～15, weight portion, Radix Aristolochiae Tagalae 20～25 weight portions, Rhizoma Dioscoreae 30～40 weight portions, Cortex Magnoliae Officinalis 20～25 weight portions, Rhizoma Iridis Japonicae 12～15 weight portions, Radix Paeoniae Alba (parched) 18～20 weight portions, Radix Glycyrrhizae Preparata 20～30 weight portions, Herba indigoferae Pseudotinctoriae 10～20 weight portions, asiatic moonseed 20～30 weight portions, Radix Polygalae Caudatae 25～35 weight portions, Herba Solani Lyrati 15～25 weight portions, Herba Pogostemonis 18～25 weight portions, Rhizoma Pinelliae (processed with Rhizoma Zingiberis Recens) 15～17 weight portions and Radix Codonopsis 20～26 weight portions.
Wherein, in described Chinese medicine preparation, the ratio of weight and number of each raw medicinal material is: Herba Sarcandrae 37 weight portions, Aspongopus 23 weight portions, Radix Tripterygii Wilfordii 8 weight portions, Pseudobulbus cremastrae seu pleiones 18 weight portions, Os Sepiae 26 weight portions, Concha Arcae (calcined) 28 weight portions, Radix Parkinsoniae 17 weight portions, Rhizoma Atractylodis 22 weight portions, the Rhizoma Atractylodis Macrocephalae 16 weight portions, Carapax Eriocheir sinensis 14 weight portions, Radix Aristolochiae Tagalae 21 weight portions, Rhizoma Dioscoreae 37 weight portions, Cortex Magnoliae Officinalis 22 weight portions, Rhizoma Iridis Japonicae 14 weight portions, Radix Paeoniae Alba (parched) 18 weight portions, Radix Glycyrrhizae Preparata 25 weight portions, Herba indigoferae Pseudotinctoriae 12 weight portions, asiatic moonseed 29 weight portions, Radix Polygalae Caudatae 33 weight portions, Herba Solani Lyrati 18 weight portions, Herba Pogostemonis 21 weight portions, Rhizoma Pinelliae (processed with Rhizoma Zingiberis Recens) 16 weight portions and Radix Codonopsis 23 weight portions.
When the dosage form of described Chinese medicine preparation is tablet, its preparation method comprises the following steps:
The first step, Herba Sarcandrae, Aspongopus, Radix Tripterygii Wilfordii, Pseudobulbus cremastrae seu pleiones, Os Sepiae, Concha Arcae (calcined), Radix Parkinsoniae, Rhizoma Atractylodis, the Rhizoma Atractylodis Macrocephalae, Carapax Eriocheir sinensis, Radix Aristolochiae Tagalae, Rhizoma Dioscoreae magnolia obovata are mixed, the alcohol reflux that to add with respect to 5 times～8 times, mixture amount determining alcohols be 70%～85% 2 times～4 times, each 3～6 hours, filter; Each time filtrate merges, and reclaims ethanol, is concentrated into the mastic that 70 ℃ of relative densities are 1.34～1.36, standby;
Second step, is mixed in proportion surplus stock medical material, adds with respect to 4～8 times of water gagings of mixture, boils 3～6 hours, filters, and is concentrated into the mastic that 70 ℃ of relative densities are 1.29～1.31;
The 3rd step, the mastic that the first step, second step are obtained mixes, and 60 ℃～70 ℃ reduced vacuum are dry, and powder gets dry extract;
The 4th step, mixes processing by described dried cream powder and starch, obtains mastic mixture; The weight ratio of described dried cream powder and starch is 1: 0.05～0.15; Described mastic mixture is carried out to pelletization treatment, dried, obtain mastic compound particles;
The 5th step, mixes processing, tabletting processing, Cotton seeds successively by described mastic compound particles and Pulvis Talci, magnesium stearate, obtains Chinese medicine preparation tablet finished product; The weight ratio of described mastic compound particles, Pulvis Talci, magnesium stearate is 100: 2～6: 0.1～0.25.
When the dosage form of described Chinese medicine preparation is oral solutions, its preparation method comprises the following steps:
The first step, Herba Sarcandrae, Aspongopus, Radix Tripterygii Wilfordii, Pseudobulbus cremastrae seu pleiones, Os Sepiae, Concha Arcae (calcined), Herba indigoferae Pseudotinctoriae, asiatic moonseed, Radix Polygalae Caudatae and Herba Solani Lyrati are mixed in proportion, the methanol that is 80%～90% with determining alcohol is as solvent, adopt percolation with the speed of 1～3ml per minute percolation slowly, collect percolate, concentrating under reduced pressure is also dry, obtains and gets dry extract, be ground into powder, the quality of the methanol adding is 5～10 times of first step mixture quality;
Second step, is mixed in proportion surplus stock medical material, is ground into powder; Add the distilled water with respect to 4～8 times of powder qualities, decoct 3～6 hours, filter, obtain the first filtrate; Filtering residue is added to the distilled water with respect to 3～5 times of its quality, decoct 2～4 hours, filter, obtain the second filtrate; Merge the first filtrate and the second filtrate, concentrate away the water of 2/3～3/4 volume, adding determining alcohol is 90%～95% ethanol, makes determining alcohol reach 60%～75%, standing 18～36 hours, filter, and concentrating under reduced pressure, dry, obtain and get dry extract, be ground into powder;
The 3rd step, mixes the powder of the first step and second step acquisition, adds the distilled water with respect to 2～6 times of amounts of mixed-powder quality, the sucrose of 0.15～0.35 times, the sodium benzoate of 0.02～0.04 times, stirs, and boils, cooling, filter, subpackage, sterilizing obtains oral liquid.
Below adopt embodiment to describe embodiments of the present invention in detail, to the present invention, how application technology means solve technical problem whereby, and the implementation procedure of reaching technique effect can fully understand and implement according to this.
Embodiment 1: tablet prepared by the present invention
Get Herba Sarcandrae 370g, Aspongopus 230g, Radix Tripterygii Wilfordii 80g, Pseudobulbus cremastrae seu pleiones 180g, Os Sepiae 260g, Concha Arcae (calcined) 280g, Radix Parkinsoniae 170g, Rhizoma Atractylodis 220g, Rhizoma Atractylodis Macrocephalae 160g, Carapax Eriocheir sinensis 140g, Radix Aristolochiae Tagalae 210g, Rhizoma Dioscoreae 370g, Cortex Magnoliae Officinalis 220g, Rhizoma Iridis Japonicae 140g, Radix Paeoniae Alba (parched) 180g, Radix Glycyrrhizae Preparata 250g, Herba indigoferae Pseudotinctoriae 120g, asiatic moonseed 290g, Radix Polygalae Caudatae 330g, Herba Solani Lyrati 180g, Herba Pogostemonis 210g, Rhizoma Pinelliae (processed with Rhizoma Zingiberis Recens) 160g and Radix Codonopsis 230g;
Its preparation method comprises the following steps:
The first step, Herba Sarcandrae, Aspongopus, Radix Tripterygii Wilfordii, Pseudobulbus cremastrae seu pleiones, Os Sepiae, Concha Arcae (calcined), Radix Parkinsoniae, Rhizoma Atractylodis, the Rhizoma Atractylodis Macrocephalae, Carapax Eriocheir sinensis, Radix Aristolochiae Tagalae, Rhizoma Dioscoreae magnolia obovata are mixed, the alcohol reflux that to add with respect to 7 times, mixture amount determining alcohols be 70% 3 times, each 5 hours, filters; Each time filtrate merges, and reclaims ethanol, is concentrated into the mastic that 70 ℃ of relative densities are 1.35, standby;
Second step, is mixed in proportion surplus stock medical material, adds with respect to 8 times of water gagings of mixture, boils 5 hours, filters, and is concentrated into the mastic that 70 ℃ of relative densities are 1.31;
The 3rd step, the mastic that the first step, second step are obtained mixes, and 65 ℃ of reduced vacuum are dry, and powder gets dry extract;
The 4th step, mixes processing by dried cream powder and starch, obtains mastic mixture; The weight ratio of dried cream powder and starch is 1: 0.09; Mastic mixture is carried out to pelletization treatment, dried, obtain mastic compound particles;
The 5th step, mixes processing, tabletting processing, Cotton seeds successively by mastic compound particles and Pulvis Talci, magnesium stearate, obtains Chinese medicine preparation tablet finished product; The weight ratio of mastic compound particles, Pulvis Talci, magnesium stearate is 100: 5: 0.15.
Oral solutions prepared by embodiment 2 the present invention
Get Herba Sarcandrae 390g, Aspongopus 210g, Radix Tripterygii Wilfordii 110g, Pseudobulbus cremastrae seu pleiones 160g, Os Sepiae 230g, Concha Arcae (calcined) 260g, Radix Parkinsoniae 190g, Rhizoma Atractylodis 170g, Rhizoma Atractylodis Macrocephalae 200g, Carapax Eriocheir sinensis 120g, Radix Aristolochiae Tagalae 240g, Rhizoma Dioscoreae 320g, Cortex Magnoliae Officinalis 240g, Rhizoma Iridis Japonicae 120g, Radix Paeoniae Alba (parched) 190g, Radix Glycyrrhizae Preparata 280g, Herba indigoferae Pseudotinctoriae 170g, asiatic moonseed 230g, Radix Polygalae Caudatae 270g, Herba Solani Lyrati 150g, Herba Pogostemonis 230g, Rhizoma Pinelliae (processed with Rhizoma Zingiberis Recens) 150g and Radix Codonopsis 210g;
Its preparation method comprises the following steps:
The first step, Herba Sarcandrae, Aspongopus, Radix Tripterygii Wilfordii, Pseudobulbus cremastrae seu pleiones, Os Sepiae, Concha Arcae (calcined), Herba indigoferae Pseudotinctoriae, asiatic moonseed, Radix Polygalae Caudatae and Herba Solani Lyrati are mixed in proportion, the methanol that is 90% with determining alcohol is as solvent, adopt percolation with the speed of 1～3ml per minute percolation slowly, collect percolate, concentrating under reduced pressure is also dry, obtains and gets dry extract, be ground into powder, the quality of the methanol adding is 7 times of first step mixture quality;
Second step, is mixed in proportion surplus stock medical material, is ground into powder; Add the distilled water with respect to 6 times of powder qualities, decoct 5 hours, filter, obtain the first filtrate; Filtering residue is added to the distilled water with respect to 4 times of its quality, decoct 3 hours, filter, obtain the second filtrate; Merge the first filtrate and the second filtrate, concentrate away the water of 2/3 volume, adding determining alcohol is 90% ethanol, makes determining alcohol reach 70%, standing 26 hours, filter, and concentrating under reduced pressure, dry, obtain and get dry extract, be ground into powder;
The 3rd step, mixes the powder of the first step and second step acquisition, adds the distilled water with respect to 4 times of amounts of mixed-powder quality, the sucrose of 0.3 times, and the sodium benzoate of 0.03 times, stirs, and boils, cooling, filter, subpackage, sterilizing obtains oral liquid.
Toxicity test:
Acute toxicity testing:
60 of application NIH mices, SPF level, male and female half and half, body weight 18～22g, carries out acute toxicity test.Mice is divided into two groups at random, and 30 every group, matched group and administration group, test front fasting 12 hours; Tablet dissolved prepared by embodiments of the invention 1 is in water, (concentration is 6.58g crude drug/ml, maximum concentration) gavage, gavage volume is 5ml/kg (being that single-dose dosage is 32.9 crude drugs/kg), matched group gives equivalent normal saline, administration in a day 2 times, delivery time 6 hours, after administration, Continuous Observation is 14 days, and record mice toxic reaction and death toll.Experimental result shows: with matched group comparison, after administration, mice has no notable difference, experiment Continuous Observation 14 days, and mice overall health of patients, diet, drinking-water, body weight gain are all normal.Mice oral administration gavage tablet LD50 of the present invention > 32.9 crude drugs/kg, every day, maximum dosage-feeding was 65.8 crude drugs/kg/ day.Chinese medicine clinical application amount of the present invention is 4.4g crude drug/day/people, becomes body weight for humans in 60KG, and average dosage is 0.073g crude drug/kg/ day.By weighing machine: the dosis tolerata of mice (average weight take 20g) oral administration gavage Chinese medicine preparation of the present invention is quantity 901 times.Therefore Chinese medicine preparation acute toxicity of the present invention is low, clinical drug safety.
Long term toxicity test:
The tablet of the embodiment of the present invention 1 to mice by 10.78,20.35 and 16 weeks (1.0ml/100g body weight of 33.48g crude drug/kg continuous use, every day 2 times) and drug withdrawal after 4 weeks, result shows: Chinese medicine preparation of the present invention all has no significant effect indexs such as the hair of rat, behavior, defecation, body weight, organ weights, hemogram, hepatic and renal function, blood glucose, blood fat, internal organs naked eyes do not find that difference changes and histological examination result shows, medication 16 weeks and drug withdrawal are after 4 weeks, and each internal organs of rat are all without obviously changing.Illustrate that toxicity is little after Chinese medicine preparation of the present invention is to rat long-term prescription, after drug withdrawal, also there is no difference reaction, application safety.
Tumor-inhibiting action test:
Subjects: 100 of ICR mices, body weight 19-24g, male.
Test inoculation content: S180 solid tumor.
Get ICR mice, in the subcutaneous conventional inoculation S180 cancerous cell suspension 0.2ml (approximately 5 * 10 of right axil
6individual cell/ml), be divided at random 5 groups next day.Treatment group is divided into three groups, is respectively high dose group, middle dosage group and low dose group, adopts the tablet of the embodiment of the present invention 1, and after pulverizing, distilled water dissolves, and every day is gastric infusion 1.2ml, 0.8ml and 0.4ml respectively, continuous 10 days; Matched group is divided into two groups, is respectively normal saline group and CTX group, and normal saline group stomach every day is raised 0.4ml normal saline, continuous 10 days; CTX group administration cyclophosphamide, administration every day 0.2g, gastric infusion after distilled water dissolves, continuous 10 days; 5 groups are after drug withdrawal and put to death animal next day, stripping tumor is weighed, calculate tumour inhibiting rate, tumour inhibiting rate formula is: the average tumor of tumour inhibiting rate (%)=(the average tumor weight of the average tumor weight-medication of normal saline matched group group)/normal saline matched group heavy * 100%, result shows, to S180, growth has inhibitory action to medicine of the present invention, and its tumour inhibiting rate increases and increases progressively with dosage, has compared significant difference P < 0.05 with matched group.To the inhibitory action of S180 and tumor killing effect in Table 1.
Table 1: to the inhibitory action of S180 and tumor killing effect
| Group | Average tumor heavy (g) | Mice average weight changes (g) | Tumour inhibiting rate (%) |
| High dose group | 1.41±0.38 | +3.95 | 56.88 |
| Middle dosage group | 1.56±0.62 | +4.42 | 52.29 |
| Low dose group | 1.67±0.26 | +4.84 | 48.93 |
| CTX group | 1.34±0.42 | -1.68 | 59.02 |
| Normal saline group | 3.27±0.89 | +5.03 | 0 |
Known by table 1: adopt the treatment group of Chinese medicine preparation of the present invention, with the comparison of normal saline group, can suppress tumor bulk-growth, and tumour inhibiting rate to increase progressively with the increase of dosage, have significant difference P < 0.05, (n=10, X ± SD); Adopt the treatment group of Chinese medicine preparation of the present invention, with CTX group relatively, the body weight of the mice for the treatment of group has increase, and the Mouse Weight of CTX group alleviates, both significant difference P < 0.05 that compared, (n=10, X ± SD).
By fluid cell instrument, measure in addition, result shows, Chinese medicine preparation of the present invention has stoped tumor cell by S → G2 process, also affected the carrying out of G1 → S simultaneously, S and the cell of G1 phase are obviously increased, the cell of G2 and M phase is relatively low, has disturbed the propagation activity of tumor cell, reaches antineoplastic action.
Clinical experiment:
1, case grouping and therapeutic scheme: by cancer of pancreas case 228 examples, male 127 examples wherein, female's 101 examples, the age, from 23 years old～69 years old, adopts random table method, patient is divided into Chinese drug-treated group, chemotherapy group and Chinese medicine at random and adds chemotherapy group;
Chinese drug-treated group 76 people, male 42 people, female 34 people, the tablet of the oral embodiment of the present invention 1, every day 3 times, each 3, every surrounding is one-period.
Chemotherapy group 76 people, male 43 people, female 33 people, chemotherapeutics is selected cisplatin (CDDP) 30mg/M2d1-3, gemzar 1000mg/M2d1,8,15, fluorouracil (5-Fu) 500mg/M2d1-5, during chemotherapy, select 2 kinds or 3 kinds of drug combinations wherein, intravenously administrable, 28 days is one-period.
Chinese medicine adds chemotherapy group 76 people, male 42 people, and female 34 people, the oral solutions of the oral embodiment of the present invention 2, every day 3 times, each 10ml, every surrounding is one-period; While intravenously administrable chemotherapeutics (the same chemotherapy group of method).
Before all patient's radiotherapies, all through pathology, confirm, and all there is x-ray to take the photograph sheet, CT scan or nuclear magnetic resonance check for clinical TNM by stages, before all doing chemotherapy by clinical criteria before chemotherapy, check that confirmation is without chemicotherapy contraindication, all patients are all without shifting cancer of pancreas (MO).
International cancer of pancreas TNM by stages with clinical stages:
International cancer of pancreas TNM is (UICC, 1987) by stages, and T refers to primary tumo(u)r situation, and N refers to lymph metastasis situation, and M refers to metastasis situation.
(1) primary tumo(u)r (T) is by stages:
Tx: can not judge; T0: without primary tumo(u)r evidence; T1: former swelling do not exceed pancreas; T1a: tumor≤2cm; T1b: tumor > 2cm; T2: tumor invading duodenum, biliary tract or pancreas surrounding tissue; T3: tumor invading stomach, spleen, colon, trunk.
(2) zonule lymph node (N) is by stages:
Nx: can not judge; NO: regional lymph nodes is without transfer; Nl: have regional lymph node metastasis;
(3) metastasis (M) is by stages:
Mx: can not judge; MO: without metastasis; Ml: have metastasis.
Clinical stages
The I phase: T1 NO MO; T1 NX MO; TX NO MO; TX NX MO.
The II phase: T2 NO MO; T2 NX MO; T3 NO MO; T3 NX MO.
The III phase: any T, N1, MO:.
The IV phase: any T, any N, Ml.
2, evaluation criteria: according to WHO treatment malignant tumor evaluation criteria evaluation curative effect, divide and alleviate (CR) completely: all visible pathological changes disappeared at least 4 weeks completely: partial rcsponse (PR): tumor size is estimated dwindle >=50% at least 4 week: unchanged (NC): without at least 4 weeks of significant change, comprise that pathological changes is stable, tumor size is estimated to expand less than 25%, dwindles less than 50%: pathological changes expansion (PD): new focus occurs or original pathological changes estimates to expand > 25%; 4 ranking pancreas portion's primary tumors and Metastatic Lymph Nodes gross tumor volume change.
3, statistical method:
With statistical package SPSS1010Wileoxon, meet rank test, paired t-test and independent sample t check.
4, result of the test:
According to above-mentioned WHO evaluation criteria, drug treatment, after 4 months, carries out short term effect statistical effect respectively, the results are shown in Table 2.
Table 2: each group short term effect tracking table record
| Group | CR | PR | NC | PD | Effective percentage (%) |
| Chinese drug-treated group | 10 | 40 | 19 | 7 | 65.79 |
| Chemotherapy group | 5 | 25 | 32 | 14 | 39.47 |
| Chinese medicine adds chemotherapy group | 14 | 42 | 16 | 4 | 73.68 |
Known by table 2, Chinese medicine preparation of the present invention in a short time (general 3-6 month) obviously dwindles lump, effectively control cancerous cell diffusion, increase clinical cure patient's ratio, and sum up and regular x-ray, CT or ultrasound diagnosis etc. by clinical observation, patient's patient's condition inquiry every day, determine that Chinese medicine preparation of the present invention can be in a short time (general 3-6 month) and alleviate fast or eliminate epigastrium distension discomfort or distending pain, jaundice, tired, loss of appetite, become thin, the symptom such as diarrhoea or constipation, alleviate patient suffering, stablize the state of an illness; Can also increase the therapeutic effect of chemotherapy, and reduce the side effect of chemotherapy simultaneously.
All patients are carried out to long-term follow record, and add up respectively survival number and survival rate when 1 year, 2 years, 3 years and 5 years, concrete data are in Table 3.
Table 3: each group long-term survival rate is followed the tracks of survival number and survival rate
| Group | 1 year | 2 years | 3 years | 5 years |
| Chinese drug-treated group | 35(46.1) | 29(38.2) | 20(26.3) | 14(18.4) |
| Chemotherapy group | 17(22.4) | 7(9.2) | 1(1.3) | 0(0) |
| Chinese medicine adds chemotherapy group | 40(52.6) | 32(42.1) | 22(28.9) | 17(22.4) |
Known by table 3, Chinese medicine preparation of the present invention can obviously improve the life span of Pancreas cancer patients, improves clinical cure patient's ratio, increases the therapeutic effect of chemotherapy and the side effect of minimizing chemotherapy simultaneously; Chinese drug-treated group and Chinese medicine add chemotherapy group, compare with chemotherapy group, have significant difference.
5, model case:
Mrs Zhao, 68 years old, cancer of pancreas late period.Because health is become thin, stomach is swollen and jaundice is admitted to hospital, check and to be diagnosed as cancer of pancreas late period.Done the chemotherapy in two stages, intravenous drip and oral chemotherapeutics combination, reaction is little, the tablet in treatment of the rear employing embodiment of the present invention 1, every day 3 times, each 3, take medicine after three months, patient's symptom disappears substantially, ailing basic alleviation, the after treatment in 1 month that continues to take medicine, follows up a case by regular visits to 2 years, patient's life aspect is all better than in the past, and appetite, spiritual complexion is all pretty good.
All above-mentioned these intellectual properties of primary enforcement, do not set restriction this new product of other forms of enforcement and/or new method.Those skilled in the art will utilize this important information, and foregoing is revised, to realize similar implementation status.But all modifications or transformation belong to the right of reservation based on new product of the present invention.
The above, be only preferred embodiment of the present invention, is not the present invention to be done to the restriction of other form, and any those skilled in the art may utilize the technology contents of above-mentioned announcement to be changed or be modified as the equivalent embodiment of equivalent variations.But every technical solution of the present invention content that do not depart from, any simple modification, equivalent variations and the remodeling above embodiment done according to technical spirit of the present invention, still belong to the protection domain of technical solution of the present invention.
Claims (7)
1. a Chinese medicine preparation for the treatment of cancer of pancreas, it is characterized in that, in described Chinese medicine preparation, the ratio of weight and number of each raw medicinal material is: Herba Sarcandrae 35～45 weight portions, Aspongopus 15～25 weight portions, Radix Tripterygii Wilfordii 6～15 weight portions, Pseudobulbus cremastrae seu pleiones 15～30 weight portions, Os Sepiae 20～40 weight portions, Concha Arcae (calcined) 15～35 weight portions, Radix Parkinsoniae 10～20 weight portions, Rhizoma Atractylodis 10～25 weight portions, the Rhizoma Atractylodis Macrocephalae 15～30 weight portions, Carapax Eriocheir sinensis 10～20 weight portions, Radix Aristolochiae Tagalae 20～30 weight portions, Rhizoma Dioscoreae 25～40 weight portions, Cortex Magnoliae Officinalis 15～25 weight portions, Rhizoma Iridis Japonicae 10～15 weight portions, Radix Paeoniae Alba (parched) 15～20 weight portions, Radix Glycyrrhizae Preparata 20～35 weight portions, Herba indigoferae Pseudotinctoriae 10～25 weight portions, asiatic moonseed 15～35 weight portions, Radix Polygalae Caudatae 20～35 weight portions, Herba Solani Lyrati 15～30 weight portions, Herba Pogostemonis 15～30 weight portions, Rhizoma Pinelliae (processed with Rhizoma Zingiberis Recens) 15～20 weight portions and Radix Codonopsis 20～30 weight portions.
2. Chinese medicine preparation as claimed in claim 1, it is characterized in that, in described Chinese medicine preparation, the ratio of weight and number of each raw medicinal material is: Herba Sarcandrae 35～40 weight portions, Aspongopus 20～25 weight portions, Radix Tripterygii Wilfordii 6～12 weight portions, Pseudobulbus cremastrae seu pleiones 15～20 weight portions, Os Sepiae 20～30 weight portions, Concha Arcae (calcined) 25～30 weight portions, Radix Parkinsoniae 15～20 weight portions, Rhizoma Atractylodis 15～25 weight portions, the Rhizoma Atractylodis Macrocephalae 15～20 weight portions, Carapax Eriocheir sinensis 10～15 weight portions, Radix Aristolochiae Tagalae 20～25 weight portions, Rhizoma Dioscoreae 30～40 weight portions, Cortex Magnoliae Officinalis 20～25 weight portions, Rhizoma Iridis Japonicae 12～15 weight portions, Radix Paeoniae Alba (parched) 18～20 weight portions, Radix Glycyrrhizae Preparata 20～30 weight portions, Herba indigoferae Pseudotinctoriae 10～20 weight portions, asiatic moonseed 20～30 weight portions, Radix Polygalae Caudatae 25～35 weight portions, Herba Solani Lyrati 15～25 weight portions, Herba Pogostemonis 18～25 weight portions, Rhizoma Pinelliae (processed with Rhizoma Zingiberis Recens) 15～17 weight portions and Radix Codonopsis 20～26 weight portions.
3. Chinese medicine preparation as claimed in claim 1, it is characterized in that, in described Chinese medicine preparation, the ratio of weight and number of each raw medicinal material is: Herba Sarcandrae 37 weight portions, Aspongopus 23 weight portions, Radix Tripterygii Wilfordii 8 weight portions, Pseudobulbus cremastrae seu pleiones 18 weight portions, Os Sepiae 26 weight portions, Concha Arcae (calcined) 28 weight portions, Radix Parkinsoniae 17 weight portions, Rhizoma Atractylodis 22 weight portions, the Rhizoma Atractylodis Macrocephalae 16 weight portions, Carapax Eriocheir sinensis 14 weight portions, Radix Aristolochiae Tagalae 21 weight portions, Rhizoma Dioscoreae 37 weight portions, Cortex Magnoliae Officinalis 22 weight portions, Rhizoma Iridis Japonicae 14 weight portions, Radix Paeoniae Alba (parched) 18 weight portions, Radix Glycyrrhizae Preparata 25 weight portions, Herba indigoferae Pseudotinctoriae 12 weight portions, asiatic moonseed 29 weight portions, Radix Polygalae Caudatae 33 weight portions, Herba Solani Lyrati 18 weight portions, Herba Pogostemonis 21 weight portions, Rhizoma Pinelliae (processed with Rhizoma Zingiberis Recens) 16 weight portions and Radix Codonopsis 23 weight portions.
4. the Chinese medicine preparation as described in claims 1 to 3 any one, is characterized in that, the dosage form of described Chinese medicine preparation is tablet, and its preparation method comprises the following steps:
The first step, Herba Sarcandrae, Aspongopus, Radix Tripterygii Wilfordii, Pseudobulbus cremastrae seu pleiones, Os Sepiae, Concha Arcae (calcined), Radix Parkinsoniae, Rhizoma Atractylodis, the Rhizoma Atractylodis Macrocephalae, Carapax Eriocheir sinensis, Radix Aristolochiae Tagalae, Rhizoma Dioscoreae magnolia obovata are mixed, the alcohol reflux that to add with respect to 5 times～8 times, mixture amount determining alcohols be 70%～85% 2 times～4 times, each 3～6 hours, filter; Each time filtrate merges, and reclaims ethanol, is concentrated into the mastic that 70 ℃ of relative densities are 1.34～1.36, standby;
Second step, is mixed in proportion surplus stock medical material, adds with respect to 4～8 times of water gagings of mixture, boils 3～6 hours, filters, and is concentrated into the mastic that 70 ℃ of relative densities are 1.29～1.31;
The 3rd step, the mastic that the first step, second step are obtained mixes, and 60 ℃～70 ℃ reduced vacuum are dry, and powder gets dry extract;
The 4th step, mixes processing by described dried cream powder and starch, obtains mastic mixture; The weight ratio of described dried cream powder and starch is 1: 0.05～0.15; Described mastic mixture is carried out to pelletization treatment, dried, obtain mastic compound particles;
The 5th step, mixes processing, tabletting processing, Cotton seeds successively by described mastic compound particles and Pulvis Talci, magnesium stearate, obtains Chinese medicine preparation tablet finished product; The weight ratio of described mastic compound particles, Pulvis Talci, magnesium stearate is 100: 2～6: 0.1～0.25.
5. the Chinese medicine preparation as described in claims 1 to 3 any one, is characterized in that, the dosage form of described Chinese medicine preparation is oral solutions, and its preparation method comprises the following steps:
The first step, Herba Sarcandrae, Aspongopus, Radix Tripterygii Wilfordii, Pseudobulbus cremastrae seu pleiones, Os Sepiae, Concha Arcae (calcined), Herba indigoferae Pseudotinctoriae, asiatic moonseed, Radix Polygalae Caudatae and Herba Solani Lyrati are mixed in proportion, the methanol that is 80%～90% with determining alcohol is as solvent, adopt percolation with the speed of 1～3ml per minute percolation slowly, collect percolate, concentrating under reduced pressure is also dry, obtains and gets dry extract, be ground into powder, the quality of the methanol adding is 5～10 times of first step mixture quality;
Second step, is mixed in proportion surplus stock medical material, is ground into powder; Add the distilled water with respect to 4～8 times of powder qualities, decoct 3～6 hours, filter, obtain the first filtrate; Filtering residue is added to the distilled water with respect to 3～5 times of its quality, decoct 2～4 hours, filter, obtain the second filtrate; Merge the first filtrate and the second filtrate, concentrate away the water of 2/3～3/4 volume, adding determining alcohol is 90%～95% ethanol, makes determining alcohol reach 60%～75%, standing 18～36 hours, filter, and concentrating under reduced pressure, dry, obtain and get dry extract, be ground into powder;
The 3rd step, mixes the powder of the first step and second step acquisition, adds the distilled water with respect to 2～6 times of amounts of mixed-powder quality, the sucrose of 0.15～0.35 times, the sodium benzoate of 0.02～0.04 times, stirs, and boils, cooling, filter, subpackage, sterilizing obtains oral liquid.
6. the preparation method of the Chinese medicine preparation as described in claims 1 to 3 any one, is characterized in that, the dosage form of described Chinese medicine preparation is tablet, and its preparation method comprises the following steps:
The first step, Herba Sarcandrae, Aspongopus, Radix Tripterygii Wilfordii, Pseudobulbus cremastrae seu pleiones, Os Sepiae, Concha Arcae (calcined), Radix Parkinsoniae, Rhizoma Atractylodis, the Rhizoma Atractylodis Macrocephalae, Carapax Eriocheir sinensis, Radix Aristolochiae Tagalae, Rhizoma Dioscoreae magnolia obovata are mixed, the alcohol reflux that to add with respect to 5 times～8 times, mixture amount determining alcohols be 70%～85% 2 times～4 times, each 3～6 hours, filter; Each time filtrate merges, and reclaims ethanol, is concentrated into the mastic that 70 ℃ of relative densities are 1.34～1.36, standby;
Second step, is mixed in proportion surplus stock medical material, adds with respect to 4～8 times of water gagings of mixture, boils 3～6 hours, filters, and is concentrated into the mastic that 70 ℃ of relative densities are 1.29～1.31;
The 3rd step, the mastic that the first step, second step are obtained mixes, and 60 ℃～70 ℃ reduced vacuum are dry, and powder gets dry extract;
The 4th step, mixes processing by described dried cream powder and starch, obtains mastic mixture; The weight ratio of described dried cream powder and starch is 1: 0.05～0.15; Described mastic mixture is carried out to pelletization treatment, dried, obtain mastic compound particles;
The 5th step, mixes processing, tabletting processing, Cotton seeds successively by described mastic compound particles and Pulvis Talci, magnesium stearate, obtains Chinese medicine preparation tablet finished product; The weight ratio of described mastic compound particles, Pulvis Talci, magnesium stearate is 100: 2～6: 0.1～0.25.
7. the preparation method of the Chinese medicine preparation described in claims 1 to 3 any one, is characterized in that, the dosage form of described Chinese medicine preparation is oral solutions, and its preparation method comprises the following steps:
The first step, Herba Sarcandrae, Aspongopus, Radix Tripterygii Wilfordii, Pseudobulbus cremastrae seu pleiones, Os Sepiae, Concha Arcae (calcined), Herba indigoferae Pseudotinctoriae, asiatic moonseed, Radix Polygalae Caudatae and Herba Solani Lyrati are mixed in proportion, the methanol that is 80%～90% with determining alcohol is as solvent, adopt percolation with the speed of 1～3ml per minute percolation slowly, collect percolate, concentrating under reduced pressure is also dry, obtains and gets dry extract, be ground into powder, the quality of the methanol adding is 5～10 times of first step mixture quality;
Second step, is mixed in proportion surplus stock medical material, is ground into powder; Add the distilled water with respect to 4～8 times of powder qualities, decoct 3～6 hours, filter, obtain the first filtrate; Filtering residue is added to the distilled water with respect to 3～5 times of its quality, decoct 2～4 hours, filter, obtain the second filtrate; Merge the first filtrate and the second filtrate, concentrate away the water of 2/3～3/4 volume, adding determining alcohol is 90%～95% ethanol, makes determining alcohol reach 60%～75%, standing 18～36 hours, filter, and concentrating under reduced pressure, dry, obtain and get dry extract, be ground into powder;
The 3rd step, mixes the powder of the first step and second step acquisition, adds the distilled water with respect to 2～6 times of amounts of mixed-powder quality, the sucrose of 0.15～0.35 times, the sodium benzoate of 0.02～0.04 times, stirs, and boils, cooling, filter, subpackage, sterilizing obtains oral liquid.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310270680.4A CN103386024B (en) | 2013-06-19 | 2013-06-19 | Traditional Chinese medicine preparation for treating pancreas cancer and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310270680.4A CN103386024B (en) | 2013-06-19 | 2013-06-19 | Traditional Chinese medicine preparation for treating pancreas cancer and preparation method thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN103386024A CN103386024A (en) | 2013-11-13 |
| CN103386024B true CN103386024B (en) | 2014-10-22 |
Family
ID=49530559
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201310270680.4A Expired - Fee Related CN103386024B (en) | 2013-06-19 | 2013-06-19 | Traditional Chinese medicine preparation for treating pancreas cancer and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103386024B (en) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104383467A (en) * | 2014-12-15 | 2015-03-04 | 许莹 | Traditional Chinese medicine for treating liver-qi depression type cervical cancer and preparation method of traditional Chinese medicine |
| CN105748846A (en) * | 2016-05-04 | 2016-07-13 | 朱宝敏 | Traditional Chinese medicine preparation for treating anemic heart disease and preparation method of traditional Chinese medicine preparation |
| CN106074828A (en) * | 2016-07-01 | 2016-11-09 | 王子熹 | A kind of Chinese medicine treating damp and hot poison Sheng type cancer of pancreas and preparation method |
| CN108403941B (en) * | 2018-05-15 | 2021-03-12 | 齐齐哈尔医学院 | Traditional Chinese medicine composition for treating pancreatic cancer and preparation method and application thereof |
Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101391088A (en) * | 2008-10-22 | 2009-03-25 | 付道成 | Enterogastritis oral medicine |
| CN101766774A (en) * | 2010-04-07 | 2010-07-07 | 泰一和浦（北京）中医药研究院有限公司 | Chinese medicine composite for treating duodenal ulcer and preparation method thereof |
| CN101780254A (en) * | 2010-02-28 | 2010-07-21 | 泰一和浦（北京）中医药研究院有限公司 | Traditional Chinese medicine compound for treating intestinal tumor and preparation method thereof |
| CN102293964A (en) * | 2011-09-01 | 2011-12-28 | 孙桂侠 | Medicine for treating gastric ulcer, and preparation method thereof |
| CN102327544A (en) * | 2008-10-24 | 2012-01-25 | 陶树发 | Traditional Chinese medicinal composition for treating cancer |
| CN102343067A (en) * | 2010-07-26 | 2012-02-08 | 丰建萍 | Traditional Chinese medicinal composition for treating pancreatitis |
| CN102824587A (en) * | 2011-07-07 | 2012-12-19 | 随洪涛 | Traditional Chinese medicinal formula for treating gastropathy |
-
2013
- 2013-06-19 CN CN201310270680.4A patent/CN103386024B/en not_active Expired - Fee Related
Patent Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101391088A (en) * | 2008-10-22 | 2009-03-25 | 付道成 | Enterogastritis oral medicine |
| CN102327544A (en) * | 2008-10-24 | 2012-01-25 | 陶树发 | Traditional Chinese medicinal composition for treating cancer |
| CN101780254A (en) * | 2010-02-28 | 2010-07-21 | 泰一和浦（北京）中医药研究院有限公司 | Traditional Chinese medicine compound for treating intestinal tumor and preparation method thereof |
| CN101766774A (en) * | 2010-04-07 | 2010-07-07 | 泰一和浦（北京）中医药研究院有限公司 | Chinese medicine composite for treating duodenal ulcer and preparation method thereof |
| CN102343067A (en) * | 2010-07-26 | 2012-02-08 | 丰建萍 | Traditional Chinese medicinal composition for treating pancreatitis |
| CN102824587A (en) * | 2011-07-07 | 2012-12-19 | 随洪涛 | Traditional Chinese medicinal formula for treating gastropathy |
| CN102293964A (en) * | 2011-09-01 | 2011-12-28 | 孙桂侠 | Medicine for treating gastric ulcer, and preparation method thereof |
Non-Patent Citations (10)
| Title |
|---|
| 中药在胰腺癌临床治疗中的研究现状;孙建平;《中国肿瘤临床与康复》;20111231;第18卷(第6期);571-573 * |
| 刘鲁明教授治疗胰腺癌的学术思想和经验特色;徐燕立等;《中华中医药学刊》;20121231;第30卷(第12期);2628-2630 * |
| 周维顺辨证治疗胰腺癌经验;唐蕾等;《浙江中西医结合杂志》;20101231;第20卷(第3期);137 * |
| 唐蕾等.周维顺辨证治疗胰腺癌经验.《浙江中西医结合杂志》.2010,第20卷(第3期),137. |
| 姚成等.沈敏鹤治疗胰腺癌经验.《深圳中西医结合杂志》.2011,第21卷(第1期),33-36. |
| 孙建平.中药在胰腺癌临床治疗中的研究现状.《中国肿瘤临床与康复》.2011,第18卷(第6期),571-573. |
| 徐燕立等.刘鲁明教授治疗胰腺癌的学术思想和经验特色.《中华中医药学刊》.2012,第30卷(第12期),2628-2630. |
| 沈敏鹤治疗胰腺癌经验;姚成等;《深圳中西医结合杂志》;20110228;第21卷(第1期);33-36 * |
| 胰腺癌中医治疗进展;金莉;《浙江中医杂志》;20121130;第47卷(第11期);855-857 * |
| 金莉.胰腺癌中医治疗进展.《浙江中医杂志》.2012,第47卷(第11期),855-857. |
Also Published As
| Publication number | Publication date |
|---|---|
| CN103386024A (en) | 2013-11-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101972338B (en) | Chinese medicinal preparation for treating infantile upper respiratory tract infection and preparation method thereof | |
| CN103719494B (en) | A kind of great burdock achene defaecation health care tea for moistening intestines and preparation method thereof | |
| CN101797326A (en) | Chinese materia medica preparation for treating borborygmus diarrhoea and preparation method thereof | |
| CN102784363A (en) | Traditional Chinese medicine composition for treating pancreatic cancer and preparation method thereof | |
| CN102205108B (en) | Traditional Chinese medicine preparation for treating gastric ulcer and preparation method thereof | |
| CN103550746A (en) | Traditional Chinese medicine preparation for treating vascular disease | |
| CN103386024B (en) | Traditional Chinese medicine preparation for treating pancreas cancer and preparation method thereof | |
| CN103736036A (en) | Drug for treating nonalcoholic fatty liver disease and preparation method thereof | |
| CN103432559B (en) | Traditional Chinese medicine composition for treating spanomenorrhea and dysmenorrhea caused by blood stasis and preparation method and application thereof | |
| CN103041256B (en) | Chinese herb preparation for curing recurrent respiratory tract infection of children | |
| CN102178818B (en) | Traditional Chinese medicinal composition for treating breast cancer and preparation method thereof | |
| CN103041257B (en) | Chinese materia medica preparation for curing high fever and respiratory tract infection of children | |
| CN105213974A (en) | One treats lymphadenomatous Chinese medicine composition and application thereof | |
| CN102727788B (en) | Chinese medicament for treating dampness-heat spleen and stomach type chronic gastritis | |
| CN103041255B (en) | Chinese materia medica preparation for curing swollen sore throat and respiratory tract infection of children | |
| CN103520686B (en) | A kind of medicine for the treatment of acquired immune deficiency syndrome (AIDS) diarrhoea | |
| CN102178866A (en) | Chinese medicinal preparation for dispelling damp, promoting blood circulation, softening hard mass and eliminating stagnation for people with qi-depression and blood-stagnation physique, preparation method thereof and application thereof | |
| CN105535839A (en) | Traditional Chinese medicine tablets for treating colon cancer and preparation method thereof | |
| CN103041258B (en) | Chinese materia medica preparation for curing respiratory tract infection with poor appetite of children | |
| CN102716341B (en) | Traditional Chinese medicinal composition for treating acute peptic ulcer bleeding and preparation method thereof | |
| CN101693096A (en) | Medicament for treating liver cancer and preparation method thereof | |
| CN105998831A (en) | Traditional Chinese medicine for treating seborrheic dermatitis and preparation method thereof | |
| CN105213897A (en) | A kind of weight gaining Chinese medicinal tablet | |
| CN105434933A (en) | Traditional Chinese medicine pill used for treating hot sweat symptom, and preparation method thereof | |
| CN104623385A (en) | Pharmaceutical compound for treating mammary gland hyperplasia and preparation method of pharmaceutical compound |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20141022 Termination date: 20150619 |
|
| EXPY | Termination of patent right or utility model |